NDC 42291-301-30 - Gabapentin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 42291-301
- Requested NDC
- 42291-301-30
- Package NDCs from labels
- 42291-301-50, 42291-301-30
- Manufacturer
- AvKARE
- Effective date
- 2022-01-13
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Gabapentin - AvKARE | AvKARE | 2022-01-13 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2013-02-13 | Indexing - Billing Unit |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 42291-301-10 | EA - Each | 42291-301 | 2148c67a-da4a-4fc6-9965-d2dc7283324f | 1 | 2013-02-13 |
| 42291-301-18 | EA - Each | 42291-301 | a94c3a5a-b7d2-4162-bcc7-69c42cf25512 | 1 | 2013-02-13 |
| 42291-301-27 | EA - Each | 42291-301 | a3157c8a-e4c6-4912-b9da-4665436ad940 | 1 | 2013-02-13 |
| 42291-301-30 | EA - Each | 42291-301 | 4b3388ae-99e2-4ac5-a747-7f90798c60a8 | 1 | 2013-02-13 |
| 42291-301-50 | EA - Each | 42291-301 | 5f4b3f45-a21d-4e20-a2e3-3296ff0a4325 | 1 | 2018-10-11 |
| 42291-301-90 | EA - Each | 42291-301 | 7169cf0d-6ae5-416d-81f2-8160bb398680 | 1 | 2013-02-13 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Gabapentin | GABAPENTIN | HAWAII REPACK, INC. | dd7adad2-e2f5-4b43-90a4-522bce0be5b3 | 2026-11-09 | Warnings, Adverse reactions | 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | Havix Group Inc d-b-a Aavis Pharmaceuticals | ad6c10e6-fc39-4ca2-942f-a56c4457e144 | 2026-11-06 | 6CW7F3G59X | |
| Gabapentin | GABAPENTIN | REMEDYREPACK INC. | 4615aaa7-73d4-4473-8f26-e7a982f8a166 | 2026-11-05 | Warnings, Adverse reactions | 310432 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | 4c49d34d-bb47-406b-8f2d-b4834b2ee9d0 | 2026-11-04 | Warnings, Adverse reactions | 310430 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | Bryant Ranch Prepack | c33c4d83-cc13-4104-9e24-d4cd40b17b70 | 2026-10-30 | Warnings, Adverse reactions | 310431 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | Bryant Ranch Prepack | 5769d849-4f27-4701-97ec-7e3ca07339d7 | 2026-10-30 | Warnings, Adverse reactions | 310430 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | a1006139-7dfc-4d87-a5a9-aeb380c32d24 | 2026-10-30 | Warnings, Adverse reactions | 310430 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | Bryant Ranch Prepack | e2d9bd8c-3bb9-4945-8e61-7d2703d9008c | 2026-10-30 | Warnings, Adverse reactions | 310430 6CW7F3G59X |
| Gabapentin | GABAPENTIN | REMEDYREPACK INC. | fb726cb0-d422-48dd-a8ed-adbde812b005 | 2026-10-29 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | d8604417-9d43-4d27-a7ce-d4120ff201f4 | 2026-10-28 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | REMEDYREPACK INC. | 7f830664-2fa3-4d73-a154-775fbb8fd65d | 2026-10-28 | Warnings, Adverse reactions | 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | 6a0a75ac-e121-477b-a9d1-d11f588afc9d | 2026-10-28 | Warnings, Adverse reactions | 310431 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | Bryant Ranch Prepack | 78088f6a-06a3-422f-b336-4a57a24adc16 | 2026-10-27 | Warnings, Adverse reactions | 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | ScieGen Pharmaceuticals, Inc. | 5ab9c18b-9568-4dcb-90b0-252aef8f8dc2 | 2026-10-23 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Ascend Laboratories, LLC | 4d445d1d-02d1-4a59-b3b2-9ba5cd924c9a | 2026-10-23 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Northwind Health Company, LLC | 552912b2-be59-0333-e063-6394a90a85c0 | 2026-10-19 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | St. Mary's Medical Park Pharmacy | 5de61c1f-8e6f-b70a-e063-6294a90a1c21 | 2026-10-15 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | PD-Rx Pharmaceuticals, Inc. | b4c7388a-19d9-4e3a-83c9-4943fb855be4 | 2026-10-14 | Warnings, Adverse reactions | 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | REMEDYREPACK INC. | e877a425-2b7f-4e43-a1f9-24019cbf9685 | 2026-10-09 | Warnings, Adverse reactions | 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Granules Pharmaceuticals Inc. | e847bcfa-f3de-404a-8a57-d8a414691e6a | 2026-10-08 | Warnings, Adverse reactions | 6CW7F3G59X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.